GlassScriptPhysician profile
Victoria Davis
NPI 1831181379
$6,207.91
in general payments reported to CMS, 2019-2025
42 companies · $959 in 2025
The $959 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $616 · 2020: $183 · 2021: $1,070 · 2022: $1,518 · 2023: $913 · 2024: $949 · 2025: $959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,537 · Education: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,537.40 |
| Education | $283.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,487.36 | 2019-2025 | Lo Loestrin Fe, Orilissa, Liletta |
| Astellas Pharma US INC | $634.61 | 2019-2025 | Veozah |
| Aspira Women'S Health INC | $318.21 | 2022-2023 | Ova1 |
| Mayne Pharma Commercial LLC | $314.46 | 2021-2025 | |
| Myovant Sciences INC. | $303.42 | 2021-2022 | |
| Biogen, INC. | $297.27 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $252.44 | 2019-2024 | |
| Organon LLC | $241.61 | 2021-2025 | Nexplanon, Jada System, Nuvaring |
| Novo Nordisk INC | $213.80 | 2023-2024 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $187.02 | 2019-2025 | |
| Coopersurgical, INC. | $172.25 | 2020-2025 | Paragard T 380a, Insorb |
| Merck Sharp & Dohme LLC | $154.19 | 2019-2024 | Gardasil 9, Gardasil |
| Mylan Pharmaceuticals INC. | $133.59 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $129.45 | 2022 | |
| Exeltis, USA INC. | $128.17 | 2022-2025 | Slynd |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $123.16 | 2021 | |
| Amag Pharmaceuticals, INC. | $100.04 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $78.49 | 2023 | Myfembree |
| Amgen INC. | $77.25 | 2024-2025 | Evenity, Prolia |
| Hologic Sales and Service, LLC | $75.87 | 2021-2024 | Acessa Provu System, Myosure Tissue Removal Device |
| Daiichi Sankyo INC. | $74.34 | 2024-2025 | Injectafer |
| Shield Therapeutics INC | $71.51 | 2022-2024 | Accrufer |
| Therapeuticsmd, INC. | $67.11 | 2019-2021 | |
| Ethicon US, LLC | $59.21 | 2021-2023 | Stratafix, Harmonic, Enseal X1 |
| Millicent US INC | $50.44 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Renovia INC | $45.32 | 2021 | |
| Lupin INC. | $44.35 | 2019-2021 | |
| Mycovia Pharmaceuticals, INC. | $40.93 | 2022-2023 | Vivjoa |
| Vertical Pharmaceuticals, LLC | $36.01 | 2019-2020 | |
| Scynexis, INC. | $34.00 | 2022 | |
| Minerva Surgical, INC | $32.70 | 2021-2022 | |
| Agile Therapeutics, INC. | $26.99 | 2022-2023 | Twirla |
| Mimedx Group, INC. | $26.61 | 2024 | |
| Evofem Biosciences, INC. | $26.08 | 2020-2021 | |
| Davol INC. | $24.92 | 2023 | Arista Ah Flexitip |
| Sanofi Pasteur INC. | $24.23 | 2025 | |
| Medicem INC. | $22.31 | 2021 | |
| Duchesnay USA Incorporated | $20.92 | 2019 | |
| Exact Sciences Corporation | $16.69 | 2025 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $16.18 | 2021 | |
| Allergan, INC. | $12.28 | 2019 | |
| Covidien LP | $12.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.